Cyclic vomiting syndrome: Timing, targets, and treatment - A basic science perspective

Digestive Diseases and Sciences

Volumn 44, Issue 8 SUPPL., 1999, Pages

  Andrews, Paul L R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cyclic vomiting syndrome; Neurokinin 1 receptor antagonists

Indexed keywords

2 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 4 (3 OXO 1,2,4 TRIAZOL 5 YLMETHYL) 3 PHENYLMORPHOLINE; 3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 5 [[3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYL 1 PIPERIDINYL]METHYL] 1,2 DIHYDRO 3H 1,2,4 TRIAZOL 3 ONE; [2 (1H INDOL 3 YLMETHYL) 1 (1 PHENYLETHYLCARBAMOYL)ETHYL]CARBAMIC ACID BENZOFURAN 2 YLMETHYL ESTER; [2 METHOXY 5 (1 TETRAZOLYL)BENZYL](2 PHENYL 3 PIPERIDINYL)AMINE; ANTIEMETIC AGENT; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

AREA POSTREMA; CHEMORECEPTOR REFLEX; CONFERENCE PAPER; DISEASE DURATION; HUMAN; NAUSEA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOLITARY TRACT NUCLEUS; SYNDROME; VOMITING;

ADOLESCENT; ADULT; ANIMALS; ANTIEMETICS; BRAIN STEM; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; HUMANS; INFANT; PERIODICITY; QUANTUM THEORY; RECEPTORS, NEUROKININ-1; RECEPTORS, OPIOID; REFLEX; SYNDROME; VOMITING;

EID: 0032847260     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Whitehead SA, Andrews PLR, Chamberlain GVP: Characterisation of nausea and vomiting in early pregnancy: A survey of 1000 women. Br J Obstet Gynaecol 12:364-369, 1992
2. Andrews PLR: Physiology of nausea and vomiting. Br J Anaesth 69:2s-19s, 1992
3. Gee S: Fitful or recurrent vomiting. Saint Bartholomew's Hospital Rep 18:1-6, 1882
4. Fleisher DR: The cyclic vomiting syndrome described. J Pediatr Gastroenterol Nutr 21:S1-S5, 1995
5. Li BUK: Cyclic Vomiting: The pattern and syndrome paradigm. J Pediatr Gastroenterol Nutr 21:S6-S10, 1995
6. Andrews P: Vomiting: an gastro-intestinal tract defensive reflex. In Pathophysiology of the Gut and Airways. P Andrews, J Widdicombe (eds). London, Portland Press, 1993, pp 97-113
7. Lang IM: Digestive tract motor correlates of vomiting and nausea. Can J Physiol Pharmacol 68:242-253, 1990
8. Miller AD, Grelot L: The neural basis of nausea and vomiting. In Vestibular Autonomic Regulation. BJ Yates, AD Miller (eds). Boca Raton, Florida, CRC Press Inc, 1996, pp 85-94
9. Grelot L, Miller AD: Neural Control of Respiratory Muscle Activation During Vomiting. In Neural Control of the Respiratory Muscles. AD Miller, AL Bianchi, Bishop BP (eds). Boca Raton, Florida, CRC Press Inc, 1996, pp 239-248
10. Andrews PLR: Why do some animals lack a vomiting reflex? In Physiol Zoology 68. Proceedings of the 4th International Congress of Comparative Physiology and Biochemistry. WW Burggren, SD Hillyard (eds). University of Chicago, 1995, p 61
11. Pelchat ML, Rozin P: The special role of nausea in the acquisition of food dislikes by humans. Appetite 3:341-351, 1982
12. 3 antiemetics. Support Care Cancer 6:244-247, 1998
13. Andrews PLR, Davis CJ, Maskell T: The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology and plasticity. Can J Physiol Pharmacol 68:325-345, 1990
14. Andrews PLR, Bhandari P, Garland S, Bingham S, Davis CJ, Hawthorn J, Davidson HIM, Roylance R, Lane S: Does retching have a function? An experimental study in the ferret. Pharmacodyn Ther (Life Sci Adv) 9:135-152, 1990
15. Andrews PLR, Torii Y, Saito H, Matsuki N: The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. Eur J Pharmacol 307:305-313, 1996
16. Fukuda H, Koga T: Hypercapnia and hypoxia which developed during retching participate in the transition from retching to expulsion in dogs. Neurosci Res 17:205-215, 1993
17. Lobel D, Eviatar L: Cyclic vertigo with predictable recurrence. Headache 38:540-546, 1998
18. Andrews PLR, Davis CJ: The mechanism of emesis induced by anti-cancer therapies. In Emesis in Anti-Cancer Therapy: Mechanisms and Treatment. PLR Andrews, GJ Sanger (eds). London, Chapman & Hall, 1993, pp. 113-161
19. Harding RK, Young RW, Anno GH: Radiotherapy-induced emesis. In Emesis in Anti-Cancer Therapy: Mechanisms and Treatment. PLR Andrews, GJ Sanger (eds). London, Chapman & Hall, 1993, pp. 163-178
20. Rudd JA, Naylor RJ: Opiod receptor involvement in emesis and anti-emesis. In Serotonin and the Scientific Basis of Anti-Emetic Therapy. DJM Reynolds, PLR Andrews, CJ Davis (eds). Oxford, Clinical Communication, 1995, pp 208-221
21. 1A receptor agonists as anti-emeties. In Serotonin and the Scientific Basis of Anti-Emetic Therapy. DJM Reynolds, PLR Andrews, CJ Davis (eds). Oxford, Clinical Communication, 1995, pp 222-227
22. Zabara J, Chaffee RB Jr, Tansy MF; Neuroinhibition in the regulation of emesis. Space Life Sci 3:282-292, 1972
23. Sekut L, Han B, Baer P, Verghese MW, Silverstein R, Clifton L, Dennis S, Numerick MJ, Connolly KM: A canine model for determination of the therapeutic index of cytokine inhibitors. Lab Anim Sci 45:647-651, 1995
24. Carpenter DO, Briggs DB, Knox AP, Strominger N: Excitation of area postrema neurons by transmitters, peptides and cyclic nucleotides. J Neurophysiol 59:358-369, 1988
25. Andrews PLR, Bhandari P: Resiniferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology 32:799-806, 1993
26. 1 receptor. Br J Pharmacol 115:84-94, 1995
27. 1 receptor antagonists act centrally to inhibit emcsis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 35:1121-1129, 1996
28. 1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs. Brain Res 802:221-131, 1998
29. 1 receptors mediate radiation-induced emesis. Gastroenterology 112:A801, 1997
30. 1 receptor antagonist. Br J Pharmacol 124:1643-1650, 1998
31. 1 receptor antagonist, in ferrets. Eur J Pharmacol 305:181-185, 1996
32. 1 receptor antagonist GR203040. Br J Pharmacol 116:3158-3163, 1995
33. 1) receptor antagonist CP-99,994. Neuropharmacology 34:1697-1699, 1995
34. 1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret. Eur J Pharmacol 321:209-216, 1997
35. 1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Eur J Pharmacol 250:R5-R6, 1993
36. 1 receptor antagonist, CP-99,994, in ferrets. Eur J Pharmacol 249:R3-R4, 1993
37. 1 receptor, and potent broad-spectrum anti-emetic activity. Regul Pept 65:45-53, 1996
38. Lucot JB, Obach RS, McLean S, Watson JW: The effect of CP-99994 on the responses to provocative motion in the cat. Br J Pharmacol 120:116-120, 1997
39. Chen Y, Saito H, Matsuki N: Ethanol-induced emesis in the house musk shrew, Suncus murinus. Life Sci 60:253-261, 1997
40. 1 receptor antagonist, on inhaled anaesthetics-induced emesis in Suncus murinus. Jpn J Pharmacol 73:212P, 1997
41. Rudd JA, Jordan CC, Naylor RJ: The action of the NK1 tachykinin receptor antagonist, CP 99,444 in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol 119:431-936, 1996